Cargando…

An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features

SIMPLE SUMMARY: The updated 4th edition WHO classification of lymphoid malignancies released in 2016 contains pivotal new terminology and information that is important for radiologists to understand. In spite of these updates, some lymphoproliferative disorders included in this update have been rare...

Descripción completa

Detalles Bibliográficos
Autores principales: Salem, Ahmed Ebada, Zaki, Yehia H., El-Hussieny, Gamal, ElNoueam, Khaled I., Shaaban, Akram M., Koppula, Bhasker Rao, Bustoros, Mark, Salama, Mohamed, Elsayes, Khaled M., Morton, Kathryn, Covington, Matthew F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616256/
https://www.ncbi.nlm.nih.gov/pubmed/34831006
http://dx.doi.org/10.3390/cancers13225853
_version_ 1784604303350038528
author Salem, Ahmed Ebada
Zaki, Yehia H.
El-Hussieny, Gamal
ElNoueam, Khaled I.
Shaaban, Akram M.
Koppula, Bhasker Rao
Bustoros, Mark
Salama, Mohamed
Elsayes, Khaled M.
Morton, Kathryn
Covington, Matthew F.
author_facet Salem, Ahmed Ebada
Zaki, Yehia H.
El-Hussieny, Gamal
ElNoueam, Khaled I.
Shaaban, Akram M.
Koppula, Bhasker Rao
Bustoros, Mark
Salama, Mohamed
Elsayes, Khaled M.
Morton, Kathryn
Covington, Matthew F.
author_sort Salem, Ahmed Ebada
collection PubMed
description SIMPLE SUMMARY: The updated 4th edition WHO classification of lymphoid malignancies released in 2016 contains pivotal new terminology and information that is important for radiologists to understand. In spite of these updates, some lymphoproliferative disorders included in this update have been rarely discussed in the radiology literature. Many of these disorders have distinct clinical and imaging features, overlapping with more common disorders, thus causing a delay in diagnosis and management. Early diagnosis of many of these disorders is key as many of these are potentially treatable because early intervention may be lifesaving. The purpose of this manuscript is to provide guidance for radiologists regarding certain rare variants of B-cell lymphoproliferative disorders, in terms of clinical, histologic, and imaging findings, as well as to incorporate the new and updated terminology of some disorders included within the 4th edition of the WHO classification of lymphoid neoplasm. ABSTRACT: Lymphoproliferative disorders (LPD) are conditions characterized by the uncontrolled proliferation of B or T-cell lines. They encompass a wide spectrum of abnormalities, which may be broadly classified as reactive processes or malignant diseases, such as lymphoma, based on their cellular clonality and clinical behavior. While some of these disorders are rare, they may be encountered sporadically in clinical practice, causing diagnostic dilemmas owing to overlap in their clinical and imaging features with more common disorders. The updated 4th edition WHO classification of lymphoid neoplasms was released in 2016 to incorporate the rapid clinical, pathological, molecular biology and cytogenetic advances of some of these disorders. Despite these updates, very little information is presented in the literature from the radiology perspective. The aim of this article is to familiarize radiologists and other physicians with certain rare variants of B-cell lymphoproliferative disorders with a focus on imaging features of these disorders, as well as to provide an overview of some important updates contained within the new WHO classification of lymphoid neoplasms.
format Online
Article
Text
id pubmed-8616256
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86162562021-11-26 An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features Salem, Ahmed Ebada Zaki, Yehia H. El-Hussieny, Gamal ElNoueam, Khaled I. Shaaban, Akram M. Koppula, Bhasker Rao Bustoros, Mark Salama, Mohamed Elsayes, Khaled M. Morton, Kathryn Covington, Matthew F. Cancers (Basel) Review SIMPLE SUMMARY: The updated 4th edition WHO classification of lymphoid malignancies released in 2016 contains pivotal new terminology and information that is important for radiologists to understand. In spite of these updates, some lymphoproliferative disorders included in this update have been rarely discussed in the radiology literature. Many of these disorders have distinct clinical and imaging features, overlapping with more common disorders, thus causing a delay in diagnosis and management. Early diagnosis of many of these disorders is key as many of these are potentially treatable because early intervention may be lifesaving. The purpose of this manuscript is to provide guidance for radiologists regarding certain rare variants of B-cell lymphoproliferative disorders, in terms of clinical, histologic, and imaging findings, as well as to incorporate the new and updated terminology of some disorders included within the 4th edition of the WHO classification of lymphoid neoplasm. ABSTRACT: Lymphoproliferative disorders (LPD) are conditions characterized by the uncontrolled proliferation of B or T-cell lines. They encompass a wide spectrum of abnormalities, which may be broadly classified as reactive processes or malignant diseases, such as lymphoma, based on their cellular clonality and clinical behavior. While some of these disorders are rare, they may be encountered sporadically in clinical practice, causing diagnostic dilemmas owing to overlap in their clinical and imaging features with more common disorders. The updated 4th edition WHO classification of lymphoid neoplasms was released in 2016 to incorporate the rapid clinical, pathological, molecular biology and cytogenetic advances of some of these disorders. Despite these updates, very little information is presented in the literature from the radiology perspective. The aim of this article is to familiarize radiologists and other physicians with certain rare variants of B-cell lymphoproliferative disorders with a focus on imaging features of these disorders, as well as to provide an overview of some important updates contained within the new WHO classification of lymphoid neoplasms. MDPI 2021-11-22 /pmc/articles/PMC8616256/ /pubmed/34831006 http://dx.doi.org/10.3390/cancers13225853 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Salem, Ahmed Ebada
Zaki, Yehia H.
El-Hussieny, Gamal
ElNoueam, Khaled I.
Shaaban, Akram M.
Koppula, Bhasker Rao
Bustoros, Mark
Salama, Mohamed
Elsayes, Khaled M.
Morton, Kathryn
Covington, Matthew F.
An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features
title An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features
title_full An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features
title_fullStr An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features
title_full_unstemmed An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features
title_short An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features
title_sort overview of selected rare b-cell lymphoproliferative disorders: imaging, histopathologic, and clinical features
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616256/
https://www.ncbi.nlm.nih.gov/pubmed/34831006
http://dx.doi.org/10.3390/cancers13225853
work_keys_str_mv AT salemahmedebada anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT zakiyehiah anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT elhussienygamal anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT elnoueamkhaledi anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT shaabanakramm anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT koppulabhaskerrao anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT bustorosmark anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT salamamohamed anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT elsayeskhaledm anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT mortonkathryn anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT covingtonmatthewf anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT salemahmedebada overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT zakiyehiah overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT elhussienygamal overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT elnoueamkhaledi overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT shaabanakramm overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT koppulabhaskerrao overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT bustorosmark overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT salamamohamed overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT elsayeskhaledm overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT mortonkathryn overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures
AT covingtonmatthewf overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures